MDR 11.6% 53.0¢ medadvisor limited

Ann: MedAdvisor signs $USD3m digital COVID-19 patient program, page-4

  1. 4,182 Posts.
    lightbulb Created with Sketch. 224
    I'm a bit confused with the timing.

    The "program launches in Q4 CY21" ...... so now.

    "The pilot is expected to be completed by the end of Q2"
    Are they still talking CY?
    So it ends in April - June 2022 (Q2CY22)?
    Or does it end December 2021 (Q2FY22)?

    "Assessment of the pilot is expected in early Q3, FY22"
    Assessment occurs before completion?
    Is it assessed in Jan-March 2022?
    Is this a one quarter program or three?

    I guess they're still getting used to reporting in AU and US fiscal years and they mean the review will be finalised in early Q1FY23 or Q3CY22 (July - Sep 2022).

    Regardless, if I'm interpreting the dates as they were meant to be reported, the program will generate AU$4M over 3 quarters. Not bad. Will definitely mean ~AU$20M for the December quarter and higher again for the March 2022 4C.

    If my interpretation and their description is wrong and this a 3 month program worth AU$4M, then look out Wednesday.

    But why confuse things referring to both FY and CY in announcements?

    Those above the equator know down here we report as FY.

    Despite getting the majority of their earnings from the US, they are listed on the ASX so I hope they can stick to one hemisphere's reporting terms.

    I expect it will be made clearer before the market opens.
 
watchlist Created with Sketch. Add MDR (ASX) to my watchlist
(20min delay)
Last
53.0¢
Change
0.055(11.6%)
Mkt cap ! $286.2M
Open High Low Value Volume
47.5¢ 53.0¢ 47.5¢ $693.3K 1.361M

Buyers (Bids)

No. Vol. Price($)
5 23499 53.0¢
 

Sellers (Offers)

Price($) Vol. No.
54.0¢ 17528 3
View Market Depth
Last trade - 14.13pm 12/07/2024 (20 minute delay) ?
MDR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.